Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older [Phase 3]
Pfizer is conducting a Phase 3 clinical trial to evaluate a Clostridioides difficile vaccine in adults 65 years and older with Clostridioide…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Multi-omics Dissection of Gut Microbiome Engraftment During FMT [NA]
Clinical trial update for a NOT_YET_RECRUITING study examining gut microbiome engraftment during fecal microbiota transplantation in recurre…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: VE303 for Prevention of Recurrent Clostridioides Difficile Infection [Phase 3]
Phase 3 clinical trial VE303 to prevent recurrence of Clostridioides difficile infection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Fecal Microbiome Transplant [Phase 1]
This is a Phase 1 clinical trial update on fecal microbiome transplantation that is currently enrolling by invitation for patients with Clos…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Difficile in Infants [NA]
A clinical trial exploring factors that influence how Clostridioides difficile colonizes and decolonizes the infant digestive tract.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection [Phase 2]
A Phase 2 clinical trial of ACX-362E (ibezapolstat) for recurrent Clostridioides difficile infection is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody [Phase 2]
Phase 2 study evaluating AZD5148 monoclonal antibody to prevent recurrent Clostridioides difficile infection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection [Phase 1]
Phase 1 trial evaluating fecal microbiota transplantation in patients undergoing colon resection; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach [Phase 1, Phase 2]
This clinical trial update reports an ongoing Phase 1/2 study comparing single infusion versus sequential fecal microbiota transplantation i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
This clinical trial update investigates how recipients' gut microbiota change after fecal microbiota transplantation in the context of preve…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Fecal Microbiota Transplantation (FMT): PRIM-DJ2727
Clinical trial update on PRIM-DJ2727 fecal microbiota transplantation for recurrent Clostridioides difficile infection and multidrug-resista…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
The REMBRANDT trial investigates recovery of the oral microbiome after antibiotic exposure in dental implant patients, sponsored by the Univ…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile [NA]
A clinical trial is evaluating pre-emptive prevention for patients at high risk of hospital-onset Clostridioides difficile infection and is …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients [Phase 1, Phase 2]
A clinical trial update for EXL01, a live biotherapeutic product intended to prevent recurrence of Clostridioides difficile infection in hig…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Xylitol Use for Decolonization of C. Difficile in Patients With IBD [Phase 1]
A Phase 1 study is investigating whether xylitol can decolonize Clostridioides difficile in patients with inflammatory bowel disease. The tr…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile [NA]
An ongoing clinical trial is evaluating fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile infection, …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: LMN-201 for Prevention of C. Difficile Infection Recurrence [Phase 2, Phase 3]
LMN-201 is being evaluated to prevent recurrence of Clostridioides difficile infection in Phase 2/Phase 3 trials, and recruitment is ongoing…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population [Phase 1]
Phase 1 trial of fecal microbiota transplantation in an expanded ulcerative colitis population; study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Clostridioides Difficile: Understanding Responses and Treatment Effects
A clinical trial update from Umeå University investigating responses and treatment effects in Clostridioides difficile infection; the study …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults [Phase 1, Phase 2]
Pfizer is conducting Phase 1/2 trials to evaluate the safety and effects of a Clostridioides difficile vaccine in healthy adults; the study …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Fecal Microbiota Transplant National Registry
ClinicalTrials.gov entry for a national registry on fecal microbiota transplant, currently recruiting to study its use in Clostridioides dif…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
Clinical trial update describing a study that measures Clostridioides difficile toxin levels in stool from healthy individuals after standar…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Vancomycin Taper to Prevent Recurrent Clostridioides Difficile [Phase 3]
Phase 3 clinical trial evaluating a vancomycin taper strategy to prevent recurrent Clostridioides difficile infection; the study is currentl…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin [Phase 2, Phase 3]
This entry describes a Phase 2/Phase 3 clinical trial evaluating oral vancomycin for primary prophylaxis of Clostridioides difficile infecti…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease [EARLY_Phase 1]
Early-phase pilot trial evaluating xylitol for de-colonization of Clostridioides difficile in patients with inflammatory bowel disease; the …